EAU Guidelines on Renal Cell Carcinoma: 2014 Update

TL;DR: Sustained action will be required to ensure that all patients with RCC in the region benefit from up-to-date care, and establishing combined genitourinary cancer clinics and formal referral systems should encourage a culture of effective communication.

TL;DR: Current evidence for cryoablation, radiofrequency ablation, and microwave ablation of T1b renal masses as well as current AUA and EAU guidelines for thermal ablation are examined.

TL;DR: To assess the potential of second‐generation proteasome inhibition by carfilzomib and its combination with the human immunodeficiency virus (Hiv) protease inhibitors (HIV‐PIs) lopinavir and nelfinavir in vitro for improved treatment of clear cell renal cell cancer (ccRCC).

TL;DR: Pretreatment LMR appears to be an independent prognostic factor of PFS and OS for patients with metastatic ccRCC after surgery, and it can be utilized to enhance the predictive ability of well‐established prognostic models.

TL;DR: A structured summary is provided including, as applicable, background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions and implications of key findings.

TL;DR: The QUOROM Statement (QUality Of Reporting Of Meta-analyses) as mentioned in this paper was developed to address the suboptimal reporting of systematic reviews and meta-analysis of randomized controlled trials.

TL;DR: Systematic reviews and meta-analyses are crucial in healthcare, informing clinical practice guidelines and research funding decisions, but their value depends on transparent and clear reporting, highlighting the need for standardized guidelines like the PRISMA statement.

TL;DR: Head and Neck Tumours.- Lip and Oral Cavity.- Pharynx.- Larynx.' Maxillary Sinus.- Salivary Glands.- Thyroid Gland.- Digestive System Tumour .